Endofotonics | 859 followers on LinkedIn. Identifying Early-stage Cancers Through In vivo Molecular Diagnosis | Endofotonics is a medtech organisation dedicated to using its proprietary Raman spectroscopy platform technology to improve early cancer detection and hence reduce cancer burden in patients. To find out more, visit us at www.endofotonics.com or email your enquiries to contact@endofotonics.com Follow and like us on facebook.com/endofotonics _ Founded in 2013, the company is headquartered in Singapore and has a subsidiary in Shanghai, China. Endofotonics developed the SPECTRA IMDx™ system, the world's first real-time in-vivo Raman spectroscopy platform, that improves early gastric cancer detection rate.